Literature DB >> 30476698

GAS: A genetic atlas selection strategy in multi-atlas segmentation framework.

Michela Antonelli1, M Jorge Cardoso2, Edward W Johnston3, Mrishta Brizmohun Appayya3, Benoit Presles4, Marc Modat2, Shonit Punwani3, Sebastien Ourselin2.   

Abstract

Multi-Atlas based Segmentation (MAS) algorithms have been successfully applied to many medical image segmentation tasks, but their success relies on a large number of atlases and good image registration performance. Choosing well-registered atlases for label fusion is vital for an accurate segmentation. This choice becomes even more crucial when the segmentation involves organs characterized by a high anatomical and pathological variability. In this paper, we propose a new genetic atlas selection strategy (GAS) that automatically chooses the best subset of atlases to be used for segmenting the target image, on the basis of both image similarity and segmentation overlap. More precisely, the key idea of GAS is that if two images are similar, the performances of an atlas for segmenting each image are similar. Since the ground truth of each atlas is known, GAS first selects a predefined number of similar images to the target, then, for each one of them, finds a near-optimal subset of atlases by means of a genetic algorithm. All these near-optimal subsets are then combined and used to segment the target image. GAS was tested on single-label and multi-label segmentation problems. In the first case, we considered the segmentation of both the whole prostate and of the left ventricle of the heart from magnetic resonance images. Regarding multi-label problems, the zonal segmentation of the prostate into peripheral and transition zone was considered. The results showed that the performance of MAS algorithms statistically improved when GAS is used.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atlas selection; Genetic algorithm; Multi-atlas based segmentation; Multi-parametric MRI; Prostate segmentation

Year:  2018        PMID: 30476698     DOI: 10.1016/j.media.2018.11.007

Source DB:  PubMed          Journal:  Med Image Anal        ISSN: 1361-8415            Impact factor:   8.545


  6 in total

1.  Brain tumor segmentation based on deep learning and an attention mechanism using MRI multi-modalities brain images.

Authors:  Ramin Ranjbarzadeh; Abbas Bagherian Kasgari; Saeid Jafarzadeh Ghoushchi; Shokofeh Anari; Maryam Naseri; Malika Bendechache
Journal:  Sci Rep       Date:  2021-05-25       Impact factor: 4.379

2.  SOMA: Subject-, object-, and modality-adapted precision atlas approach for automatic anatomy recognition and delineation in medical images.

Authors:  Jieyu Li; Jayaram K Udupa; Dewey Odhner; Yubing Tong; Drew A Torigian
Journal:  Med Phys       Date:  2021-11-18       Impact factor: 4.071

Review 3.  Multi-atlas image registration of clinical data with automated quality assessment using ventricle segmentation.

Authors:  Florian Dubost; Marleen de Bruijne; Marco Nardin; Adrian V Dalca; Kathleen L Donahue; Anne-Katrin Giese; Mark R Etherton; Ona Wu; Marius de Groot; Wiro Niessen; Meike Vernooij; Natalia S Rost; Markus D Schirmer
Journal:  Med Image Anal       Date:  2020-04-18       Impact factor: 8.545

4.  Diagnosis of Multiple Sclerosis Disease in Brain Magnetic Resonance Imaging Based on the Harris Hawks Optimization Algorithm.

Authors:  Amal F A Iswisi; Oğuz Karan; Javad Rahebi
Journal:  Biomed Res Int       Date:  2021-12-27       Impact factor: 3.411

5.  AutoProstate: Towards Automated Reporting of Prostate MRI for Prostate Cancer Assessment Using Deep Learning.

Authors:  Pritesh Mehta; Michela Antonelli; Saurabh Singh; Natalia Grondecka; Edward W Johnston; Hashim U Ahmed; Mark Emberton; Shonit Punwani; Sébastien Ourselin
Journal:  Cancers (Basel)       Date:  2021-12-06       Impact factor: 6.639

6.  Semi-Automatic Prostate Segmentation From Ultrasound Images Using Machine Learning and Principal Curve Based on Interpretable Mathematical Model Expression.

Authors:  Tao Peng; Caiyin Tang; Yiyun Wu; Jing Cai
Journal:  Front Oncol       Date:  2022-06-07       Impact factor: 5.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.